Kentaro Nakai Selected Research

5- (2- (1- (1- (3- hydroxy- 2,3- dimethylbutoxy)ethyl)- 7alpha- methyldihydro- 1H- inden- 4(2H,5H,6H,7H,7alphaH)- ylidene)ethylidene)- 2- methylenecyclohexane- 1,3- diol

1/2017

Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Nakai Research Topics

Disease

14	Chronic Renal Insufficiency 09/2019 - 10/2009
6	Atrial Fibrillation 05/2020 - 07/2014
6	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 04/2011
5	Type 2 Diabetes Mellitus (MODY) 12/2015 - 01/2010
4	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 02/2018 - 10/2009
3	Hypophosphatemia 09/2019 - 01/2016
2	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 03/2009
2	Hypercalcemia (Milk Alkali Syndrome) 01/2021 - 01/2017
2	Vascular Calcification 01/2018 - 01/2017
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2017 - 12/2012
2	Hyperphosphatemia 01/2017 - 11/2010
2	Glomerulonephritis 01/2017 - 01/2015
2	Hemorrhage 01/2017 - 07/2014
2	Stroke (Strokes) 09/2016 - 07/2014
2	Myocardial Infarction 04/2016 - 08/2012
2	Fibrosis (Cirrhosis) 12/2015 - 04/2011
2	Diabetes Mellitus 12/2015 - 01/2013
2	Hyperparathyroidism 12/2015 - 01/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 09/2015 - 04/2014
2	Bone Diseases (Bone Disease) 05/2015 - 01/2011
1	Peripheral Arterial Disease 11/2022
1	Nephrogenic Diabetes Insipidus 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Diabetes Insipidus 01/2021
1	Polyuria 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Cardiovascular Abnormalities 01/2018
1	Hypertension (High Blood Pressure) 08/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2017
1	Weight Loss (Weight Reduction) 08/2017
1	Vasculitis (Vasculitides) 01/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2017
1	Fanconi Syndrome (Syndrome, Fanconi) 10/2016
1	Osteoporosis 09/2016
1	Breast Neoplasms (Breast Cancer) 09/2016
1	Cardiac Arrhythmias (Arrythmia) 02/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Arteriolosclerosis 01/2016
1	Body Weight (Weight, Body) 12/2015
1	Tachycardia (Tachyarrhythmias) 12/2015
1	Disease Progression 12/2014
1	Albuminuria 04/2014
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2014
1	Kidney Diseases (Kidney Disease) 02/2013
1	Fabry Disease (Fabry's Disease) 12/2012

Drug/Important Bio-Agent (IBA)

7	Vitamin D FDA LinkGeneric 01/2017 - 10/2009
5	Phosphates (Orthophosphate)IBA 09/2019 - 11/2010
4	MineralsIBA 02/2018 - 10/2009
4	CalciumIBA 01/2018 - 10/2009
4	maxacalcitolIBA 12/2015 - 01/2013
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017 - 05/2015
3	AST 120IBA 04/2016 - 04/2011
3	CreatinineIBA 12/2015 - 03/2009
3	Parathyroid Hormone (Parathormone)IBA 12/2015 - 10/2009
2	paricalcitol (Zemplar)FDA Link 02/2018 - 01/2017
2	1,25-dihydroxyvitamin DIBA 10/2016 - 11/2010
2	Anti-Arrhythmia AgentsIBA 02/2016 - 12/2015
2	Cinacalcet (Sensipar)FDA Link 12/2015 - 10/2009
2	Phosphorus (Red Phosphorus)IBA 12/2015 - 10/2009
2	Carvedilol (Coreg)FDA LinkGeneric 09/2015 - 01/2011
2	Fibroblast Growth Factor-23IBA 12/2014 - 11/2010
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2014 - 12/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 01/2010
2	Uremic ToxinsIBA 06/2013 - 04/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022
1	LithiumIBA 01/2021
1	Triamterene (Dyrenium)FDA LinkGeneric 01/2021
1	Indapamide FDA LinkGeneric 01/2021
1	APTIBA 01/2019
1	lanthanum carbonate (Fosrenol)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 12/2017
1	Tyrosine Kinase InhibitorsIBA 08/2017
1	Antihypertensive Agents (Antihypertensives)IBA 08/2017
1	5- (2- (1- (1- (3- hydroxy- 2,3- dimethylbutoxy)ethyl)- 7alpha- methyldihydro- 1H- inden- 4(2H,5H,6H,7H,7alphaH)- ylidene)ethylidene)- 2- methylenecyclohexane- 1,3- diolIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 09/2016
1	mahuang-tangIBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 12/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2015
1	Alkaline PhosphataseIBA 12/2015
1	8-Hydroxy-2'-DeoxyguanosineIBA 12/2015
1	PTX3 proteinIBA 01/2015
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2015
1	C-Reactive ProteinIBA 01/2015
1	Dietary PhosphorusIBA 12/2014
1	AnticoagulantsIBA 07/2014
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2014
1	Insulin (Novolin)FDA Link 01/2013

Therapy/Procedure

7	Therapeutics 01/2019 - 11/2010
5	Renal Dialysis (Hemodialysis) 01/2018 - 01/2014
3	Catheter Ablation 12/2017 - 12/2015
2	Kidney Transplantation 09/2019 - 12/2015
2	Transplantation 09/2019 - 12/2015
2	Parathyroidectomy 12/2015 - 01/2014
1	Blood Pressure Monitors 05/2020
1	Stents 01/2019
1	Plasma Exchange 01/2017
1	Protein-Restricted Diet (Diet, Protein Restricted) 12/2014
1	Percutaneous Coronary Intervention 07/2014